Trending in Texoma — Volcanic eruption to manners with machines
WICHITA FALLS (KFDX/KJTL) — Whether it's happening on the other side of the country, somewhere else in Texas, or right in our communities, Digital Producer Mariana Vela takes a look at the stories currently generating the most interest on social media.
Social Rundown: New Jersey wildfire, New Zealand animal extinctions, Maryland Zoo grizzly bears
'Magic Number'
A survey polled more than 4,600 adults, which showed the numbers that would allow Americans to retire comfortably. $1.26 million is the number. But the magic number is $200,000 down from last year.
Poas Volcano
After two eruptions this week, the Poas Volcano in Costa Rica has covered the island in ash. This volcano is a popular tourist attraction, and scientists warn that when a volcano goes silent, an eruption could soon follow.
Chatbots and niceness.
Being nice to chatbots could be costing OpenAI big amounts. According to one study, an AI response consumes as much energy as keeping fourteen LED bulbs lit for an hour.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Eating more of these plant-based foods could lower your risk of heart disease and diabetes
Eating more nuts, fruits, vegetables, and whole grains may help to reduce your risk of contracting deadly heart disease and type 2 diabetes. Researchers said this week that people who consumed more phytosterols — a natural compound found in plant foods — significantly delayed both of the conditions. Furthermore, eating more of them was linked to reduced inflammation, markers of better insulin regulation, and differences in the gut microbiome that may contribute to healthy metabolism. The study was not designed to confirm why this is the case, but the researchers said their findings strengthen the evidence. More than 7000,000 Americans die from heart disease and some 101,000 die from diabetes. 'Our findings support the dietary recommendation of adhering to healthy plant-based dietary patterns that are rich in vegetables, fruits, nuts and whole grains,' Dr. Fenglei Wang, a research associate at the Harvard T.H. Chan School of Public Health, said in a statement. 'These findings can help people make informed dietary choices.' Wang presented the observational findings on Tuesday at the flagship annual meeting of the American Society for Nutrition. Some phytosterol-rich foods include corn, almonds, broccoli, bananas, and wheat bread. Previous research had found that eating foods with phytosterols can help to improve peoples' health by lowering bad cholesterol, and may reduce the risk of cancer. However, most clinical trials have used high doses of the phytosterols that were beyond what someone might get through just their own diet. The new research is the first to show the benefits as part of a normal diet. To reach these conclusions, Wang and his colleagues looked at data from more than 200,000 American adults that were a part of three studies. All of the participants were nurses or other health professionals and nearly 80 percent were women. Over the course of 36 years, more than 20,000 of them developed type 2 diabetes and nearly 16,000 developed heart disease. The participants' answers to food-frequency questionnaires allowed the researchers to estimate their individual intake of phytosterols, as well as three individual phytosterols known as β-sitosterol, campesterol and stigmasterol. Those who ate the most consumed the most phytosterol had about four to five servings of vegetables, two to three servings of fruits, two servings of whole grains, and half a serving of nuts each day. This made them 9 percent less likely to develop heart disease and 8 percent less likely to develop type 2 diabetes compares to those in the bottom fifth percentage for phytosterol intake, the research showed. Looking at the individual phytosterols, similar associations were observed for β-sitosterol. But, the same was not true for campesterol or stigmasterol. In addition, the researchers analyzed blood samples, looking at the products of metabolism — also known as metabolites — from more than 11,000 people and other metabolic biomarkers in blood samples from over 40,000 participants. They found that phytosterol and β-sitosterol levels were tied to favorable metabolites and metabolic markers relevant to heart disease and diabetes. That signaled a possible reason for the association. 'Our clinical biomarker and metabolomic results suggest the involvement of insulin activity, inflammation and the metabolism of metabolites associated with type 2 diabetes and cardiovascular disease,' said Wang. 'This suggests that phytosterol might reduce risk by alleviating insulin resistance and inflammation.' In a group of just 465 participants, they examined the gut microbiome, or the trillions of microscopic organisms inside the intestines. They found several microbial species and related enzymes linked to higher intake of phytosterols that may affect the production of metabolites associated with a lower risk of diseases. 'We found that the gut microbiome might play a role in the beneficial associations. Some species, such as Faecalibacterium prausnitzii, carry enzymes that could help degrade phytosterol, potentially influencing host metabolism,' Wang said.
Yahoo
8 hours ago
- Yahoo
Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction
Parents pursuing IVF now have a new level of choice to empower their family planning NEW YORK, June 4, 2025 /PRNewswire/ -- With U.S. birthrates plummeting and IVF on the rise, Nucleus Genomics today launched Nucleus Embryo, the first genetic optimization software that lets parents see and understand a complete genetic profile to select an embryo. "Before there's a heartbeat, there's DNA," said Kian Sadeghi, founder and CEO of Nucleus. "One file containing DNA and genetic markers can tell you more about your baby's future than any other test a doctor could possibly run at this stage. Most clinics stop at whether an embryo will develop. For many parents, that's not enough. Patients have long asked for more transparency from clinics, and Nucleus Embryo is an important step toward complete data ownership for parents planning their families." The software enables parents to analyze and compare up to 20 embryos across over 900 hereditary conditions and 40 additional analyses beyond basic viability, spanning cancers, chronic conditions, appearance, cognitive ability, mental health, and more. To widen access to the software, Nucleus will partner with Genomic Prediction, the first company to offer genome-wide screening on embryos. The partnership sets a new standard in genetic medicine, continuing Genomic Prediction's decade-long history of giving hopeful parents the best possible chance of implanting healthy embryos. The company's analyses focus on hereditary conditions, acting as the first line of defense against chronic and rare diseases. "As an organization, we are committed to supporting patients' rights to their DNA and any information that can aid in their family-building journey," said Kelly Ketterson, CEO of Genomic Prediction. "We have a legacy of innovation aimed at providing patients with access to the best scientific resources. Our partnership with Nucleus opens access to information our patients have requested and allows us to uphold our commitment to this legacy." Nucleus' partnership with Genomic Prediction reflects a growing shift in how parents think about genetics as a tool to give children the best possible start in life. A wide-ranging study of Americans found the majority accepted the use of genetic technology to choose embryos based on health and personality traits. Four in 10 parents would use genetic optimization as another tool to understand their future child's cognitive abilities. Most women undergo three to six IVF cycles before successfully having a baby, with each cycle costing up to $25,000. Many embryos are unviable within days of being fertilized, leaving parents with few to choose from. Facing high stakes, clinicians often recommend genetic testing to optimize a couple's chances of a healthy pregnancy. But these tests typically stop at a select number of hereditary conditions and chromosome count. Now, advanced genetic analysis from Nucleus gives parents a new window into the health and well-being of their future child. Nucleus Embryo provides a comprehensive genetic profile for each embryo, encompassing hereditary genetic diseases, like cystic fibrosis and hemochromatosis, alongside genetic measures of cognitive ability, mental health, and risk for chronic diseases. Wide access to genetic insights for embryos can also help extend lifespan from the earliest stages of life. While more than half of all deaths annually in the U.S. are attributed to chronic, age-related conditions — such as Alzheimer's disease, diabetes, cancer, and heart disease — research shows embryonic selection can materially help reduce disease risk for these conditions. "We celebrate health optimization and the pursuit of longevity in every other part of life via our focus on training, supplements, and sleep," Sadeghi said. "We all know health isn't just the absence of disease. It's the ability to understand our bodies and genetic makeup to reach our full potential. Now we can apply this principle to life's inception." About Nucleus Genomics Nucleus builds software for generational health. Inspired by the loss of his cousin who died of a rare — yet preventable — genetic disease, Nucleus founder and Thiel Fellow Kian Sadeghi left an Ivy League university to build a product that could have saved her life. Our advanced DNA health test and analysis takes the guesswork out of your health, whether it's perfecting your protocols, knowing your risk for cancer, or planning for a healthy family. Follow us on social media @nucleusgenomics. About Genomic Prediction Genomic Prediction, Inc. is the frontrunner in advanced embryo screening. Our proprietary LifeView platform is state-of-the-art technology that assesses embryos for genetic health aimed at improved IVF outcomes. The LifeView Embryo Health Score Test (EHS) offers insight into the likelihood of developing conditions driven by multiple genes. It tests for significant health issues, including cardiovascular disease, diabetes mellitus, certain cancers, and mental health conditions. The EHS results are derived from the same embryo sample used in the following PGT tests: PGT-A: Identifies chromosome abnormalities in embryos. PGT-A+: Pinpoints the origin (paternal, maternal, or embryonic) of chromosome abnormalities. PGT-M: Decreases the chances of passing on monogenic (single-gene) conditions. PGT-SR: Detects chromosome abnormalities and structural imbalances, providing clarity between normal and balanced chromosomes. View original content to download multimedia: SOURCE Nucleus
Yahoo
8 hours ago
- Yahoo
Inside the Secret Meeting Where Mathematicians Struggled to Outsmart AI
On a weekend in mid-May, a clandestine mathematical conclave convened. Thirty of the world's most renowned mathematicians traveled to Berkeley, Calif., with some coming from as far away as the U.K. The group's members faced off in a showdown with a 'reasoning' chatbot that was tasked with solving problems they had devised to test its mathematical mettle. After throwing professor-level questions at the bot for two days, the researchers were stunned to discover it was capable of answering some of the world's hardest solvable problems. 'I have colleagues who literally said these models are approaching mathematical genius,' says Ken Ono, a mathematician at the University of Virginia and a leader and judge at the meeting. The chatbot in question is powered by o4-mini, a so-called reasoning large language model (LLM). It was trained by OpenAI to be capable of making highly intricate deductions. Google's equivalent, Gemini 2.5 Flash, has similar abilities. Like the LLMs that powered earlier versions of ChatGPT, o4-mini learns to predict the next word in a sequence. Compared with those earlier LLMs, however, o4-mini and its equivalents are lighter-weight, more nimble models that train on specialized datasets with stronger reinforcement from humans. The approach leads to a chatbot capable of diving much deeper into complex problems in math than traditional LLMs. To track the progress of o4-mini, OpenAI previously tasked Epoch AI, a nonprofit that benchmarks LLMs, to come up with 300 math questions whose solutions had not yet been published. Even traditional LLMs can correctly answer many complicated math questions. Yet when Epoch AI asked several such models these questions, which were dissimilar to those they had been trained on, the most successful were able to solve less than 2 percent, showing these LLMs lacked the ability to reason. But o4-mini would prove to be very different. [Sign up for Today in Science, a free daily newsletter] Epoch AI hired Elliot Glazer, who had recently finished his math Ph.D., to join the new collaboration for the benchmark, dubbed FrontierMath, in September 2024. The project collected novel questions over varying tiers of difficulty, with the first three tiers covering undergraduate-, graduate- and research-level challenges. By February 2025, Glazer found that o4-mini could solve around 20 percent of the questions. He then moved on to a fourth tier: 100 questions that would be challenging even for an academic mathematician. Only a small group of people in the world would be capable of developing such questions, let alone answering them. The mathematicians who participated had to sign a nondisclosure agreement requiring them to communicate solely via the messaging app Signal. Other forms of contact, such as traditional e-mail, could potentially be scanned by an LLM and inadvertently train it, thereby contaminating the dataset. The group made slow, steady progress in finding questions. But Glazer wanted to speed things up, so Epoch AI hosted the in-person meeting on Saturday, May 17, and Sunday, May 18. There, the participants would finalize the final batch of challenge questions. Ono split the 30 attendees into groups of six. For two days, the academics competed against themselves to devise problems that they could solve but would trip up the AI reasoning bot. Each problem the o4-mini couldn't solve would garner the mathematician who came up with it a $7,500 reward. By the end of that Saturday night, Ono was frustrated with the bot, whose unexpected mathematical prowess was foiling the group's progress. 'I came up with a problem which experts in my field would recognize as an open question in number theory—a good Ph.D.-level problem,' he says. He asked o4-mini to solve the question. Over the next 10 minutes, Ono watched in stunned silence as the bot unfurled a solution in real time, showing its reasoning process along the way. The bot spent the first two minutes finding and mastering the related literature in the field. Then it wrote on the screen that it wanted to try solving a simpler 'toy' version of the question first in order to learn. A few minutes later, it wrote that it was finally prepared to solve the more difficult problem. Five minutes after that, o4-mini presented a correct but sassy solution. 'It was starting to get really cheeky,' says Ono, who is also a freelance mathematical consultant for Epoch AI. 'And at the end, it says, 'No citation necessary because the mystery number was computed by me!'' Defeated, Ono jumped onto Signal early that Sunday morning and alerted the rest of the participants. 'I was not prepared to be contending with an LLM like this,' he says, 'I've never seen that kind of reasoning before in models. That's what a scientist does. That's frightening.' Although the group did eventually succeed in finding 10 questions that stymied the bot, the researchers were astonished by how far AI had progressed in the span of one year. Ono likened it to working with a 'strong collaborator.' Yang Hui He, a mathematician at the London Institute for Mathematical Sciences and an early pioneer of using AI in math, says, 'This is what a very, very good graduate student would be doing—in fact, more.' The bot was also much faster than a professional mathematician, taking mere minutes to do what it would take such a human expert weeks or months to complete. While sparring with o4-mini was thrilling, its progress was also alarming. Ono and He express concern that the o4-mini's results might be trusted too much. 'There's proof by induction, proof by contradiction, and then proof by intimidation,' He says. 'If you say something with enough authority, people just get scared. I think o4-mini has mastered proof by intimidation; it says everything with so much confidence.' By the end of the meeting, the group started to consider what the future might look like for mathematicians. Discussions turned to the inevitable 'tier five'—questions that even the best mathematicians couldn't solve. If AI reaches that level, the role of mathematicians would undergo a sharp change. For instance, mathematicians may shift to simply posing questions and interacting with reasoning-bots to help them discover new mathematical truths, much the same as a professor does with graduate students. As such, Ono predicts that nurturing creativity in higher education will be a key in keeping mathematics going for future generations. 'I've been telling my colleagues that it's a grave mistake to say that generalized artificial intelligence will never come, [that] it's just a computer,' Ono says. 'I don't want to add to the hysteria, but in many ways these large language models are already outperforming most of our best graduate students in the world.'
